Identifying Important Risk Indicators in Clinical Development

Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams and considered an essential component of centralized monitoring.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

ICH E6(R3), Demystified Part 4: Informed Consent

From Signature to System: Why E6(R3) Raises the Bar For years, informed consent has too often...

Blog

RBQM for the Mid-Market Explained

Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with...

Blog

5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires

Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a...